Avant Brands Inc. (AVNT.TO)
CAD 0.53
(1.92%)
CAD 0.53
(1.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 82.55 Million CAD | 23.15% |
| 2022 | 67.03 Million CAD | 32.55% |
| 2021 | 50.57 Million CAD | 23.95% |
| 2020 | 40.8 Million CAD | -9.96% |
| 2019 | 45.31 Million CAD | 12.4% |
| 2018 | 40.31 Million CAD | 22531.27% |
| 2017 | 178.14 Thousand CAD | 356.56% |
| 2016 | 39.01 Thousand CAD | -72.42% |
| 2015 | 141.45 Thousand CAD | 384.55% |
| 2014 | 29.19 Thousand CAD | -83.01% |
| 2013 | 171.82 Thousand CAD | 38.15% |
| 2012 | 124.37 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 74.43 Million CAD | -7.62% |
| 2024 Q3 | 72.56 Million CAD | -2.51% |
| 2024 Q1 | 80.56 Million CAD | -2.4% |
| 2023 FY | 82.55 Million CAD | 23.15% |
| 2023 Q2 | 78.3 Million CAD | -0.4% |
| 2023 Q3 | 87.52 Million CAD | 11.77% |
| 2023 Q1 | 78.62 Million CAD | 17.29% |
| 2023 Q4 | 82.55 Million CAD | -5.68% |
| 2022 Q1 | 50.15 Million CAD | -0.82% |
| 2022 FY | 67.03 Million CAD | 32.55% |
| 2022 Q4 | 67.03 Million CAD | -5.24% |
| 2022 Q3 | 70.73 Million CAD | 41.65% |
| 2022 Q2 | 49.93 Million CAD | -0.44% |
| 2021 Q1 | 42.79 Million CAD | 4.88% |
| 2021 FY | 50.57 Million CAD | 23.95% |
| 2021 Q4 | 50.57 Million CAD | -12.51% |
| 2021 Q3 | 57.79 Million CAD | -4.32% |
| 2021 Q2 | 60.4 Million CAD | 41.16% |
| 2020 Q2 | 45.4 Million CAD | -0.08% |
| 2020 FY | 40.8 Million CAD | -9.96% |
| 2020 Q4 | 40.8 Million CAD | -11.09% |
| 2020 Q3 | 45.88 Million CAD | 1.07% |
| 2020 Q1 | 45.44 Million CAD | 0.28% |
| 2019 Q2 | 48.4 Million CAD | 8.88% |
| 2019 Q3 | 47.17 Million CAD | -2.53% |
| 2019 FY | 45.31 Million CAD | 12.4% |
| 2019 Q1 | 44.45 Million CAD | 10.27% |
| 2019 Q4 | 45.31 Million CAD | -3.94% |
| 2018 Q1 | 149.03 Thousand CAD | -16.34% |
| 2018 FY | 40.31 Million CAD | 22531.27% |
| 2018 Q4 | 40.31 Million CAD | 6.49% |
| 2018 Q3 | 37.85 Million CAD | 41.07% |
| 2018 Q2 | 26.83 Million CAD | 17906.55% |
| 2017 Q2 | 338.85 Thousand CAD | 1388.76% |
| 2017 Q1 | 22.76 Thousand CAD | -41.67% |
| 2017 FY | 178.14 Thousand CAD | 356.56% |
| 2017 Q4 | 178.14 Thousand CAD | -9.65% |
| 2017 Q3 | 197.16 Thousand CAD | -41.81% |
| 2016 Q1 | 165.89 Thousand CAD | 17.27% |
| 2016 Q2 | 98.43 Thousand CAD | -40.67% |
| 2016 Q4 | 39.01 Thousand CAD | -12.63% |
| 2016 Q3 | 44.66 Thousand CAD | -54.63% |
| 2016 FY | 39.01 Thousand CAD | -72.42% |
| 2015 Q3 | 196.24 Thousand CAD | 574.23% |
| 2015 FY | 141.45 Thousand CAD | 384.55% |
| 2015 Q4 | 141.45 Thousand CAD | -27.92% |
| 2015 Q1 | 29.92 Thousand CAD | 2.5% |
| 2015 Q2 | 29.1 Thousand CAD | -2.73% |
| 2014 Q4 | 29.19 Thousand CAD | -55.96% |
| 2014 FY | 29.19 Thousand CAD | -83.01% |
| 2014 Q1 | 114.01 Thousand CAD | -33.64% |
| 2014 Q3 | 66.28 Thousand CAD | -41.86% |
| 2014 Q2 | 114.01 Thousand CAD | 0.0% |
| 2013 Q4 | 171.82 Thousand CAD | -37.45% |
| 2013 Q1 | 128.78 Thousand CAD | 0.0% |
| 2013 FY | 171.82 Thousand CAD | 38.15% |
| 2013 Q2 | 124.78 Thousand CAD | -3.11% |
| 2013 Q3 | 274.68 Thousand CAD | 120.13% |
| 2012 FY | 124.37 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 90.157% |
| Avicanna Inc. | 21.97 Million CAD | -275.73% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -124.934% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -235.605% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 91.269% |
| MediPharm Labs Corp. | 63.93 Million CAD | -29.115% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | 72.34% |
| Canopy Growth Corporation | 1.3 Billion CAD | 93.651% |
| Willow Biosciences Inc. | 6.67 Million CAD | -1137.105% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | 68.48% |